HIFs are heterodimeric transcription factors, consisting of an oxygen-labile alpha subunit (HIF-α) and a constitutivelystable beta subunit (HIF-β), that exert pivotal roles in inducing cellular responses to hypoxia. HIF-1α and HIF-2α are hydroxylated by prolyl hydroxylases (PHD) and degraded after binding to protein von Hippel Lindau (pVHL) under normoxic conditions. Our in vitro analyses demonstrated that LPS or BCR-mediated activation of B cells can also induce the expression of HIF-1α, but not HIF-2α, in an oxygen-independent way. HIF-1α expression in BCR-stimulated B cells is promoted by the ERK-STAT3 signaling pathway. Following B cell activation, phosphorylated STAT3 at position Ser727 transcriptionally induces the Hif1a gene.
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We also explored the role of HIFs during B lymphocytes development in vivo by crossing mice carrying a loxPflanked Hif1a or Hif2a allele with mice expressing cre recombinase from the Mb1 promoter (referred to herein as
Our results showed that HIF-2α has no essential role during B cell development, whereas HIF-1α is important for B1a population in the peritoneum. B1a cells possess regulatory functions and produce the anti-inflammatory cytokine IL-10 after activation. Next, we focused on whether IL-10 is altered by loss of HIF-1α in B cells. Indeed, we observed that the frequency of IL-10-producing B cells in bone marrow, spleen, inguinal lymph nodes and the peritoneal cavity were decreased in Mb1 cre Hif1a f/f mice. Our findings showed that HIF-1α is an important factor for IL-10-producing B cells.
HIF-1α has previously been shown to act as a key factor in the reprogramming of immune cells metabolism by activating transcription of genes encoding glucose transporters and glycolytic enzymes, which import glucose and convert it into lactate. HIF-1α-mediated shift from oxidative to glycolytic metabolism regulates immune cell function and proliferation. We found that CD1d + B cell expansion. This work provided a new insight into the role of HIF-1α for IL-10-producing B cells.
Next, we delineated the physiological relevance of the immunoregulation of HIF-1α on IL-10-producing B cells and the protective role of HIF-1α-deficient B cells in autoimmune disease. Our data showed that impaired IL-10 production by HIF-1α-dependent B cells is associated with decreased Tr1 cells, indicating a regulatory network between IL-10-producing B cells and Tr1 cells. In addition, increased IL-17 and IFN-γ production in Hif1a-deficient mice is associated with a strong exacerbation of experimental autoimmune encephalomyelitis (EAE) and inflammatory arthritis. Our findings indicate that HIF-1α is a key element for IL-10-producing B cell proliferation and IL-10 signaling, thereby influencing the course of T cell mediated autoimmune diseases such as EAE and arthritis (Figure 1) . In summary, we provide a novel molecular mechanism for the regulation of IL-10 producing B cells by HIF-1α. By modulating glycolytic metabolism, HIF-1α regulates IL-10-producing B cell expansion. Moreover, we identified HIF-1α as a critical node involved in IL-10 production by B cells. HIF-1α effectively binds to hypoxia response elements in the Il10 promoter, leading to induced expression of B cell derived IL-10. In consequence, HIF-1α expression in B cells regulates autoimmune disease.
One of the most obvious unanswered questions is whether a glycolytic gene signature controlling expansion of IL-10-producing B cells exist. Data from our group show that many glycolytic genes such as Glut1, Pkm2, Hk2, Ldha, Pdk1 and Gpi1, were decreased in Hif1a-deficient CD1d hi CD5 + B cells. B lymphocytes must adapt to a wide array of environmental stressors as part of their normal development, where they undergo a dramatic metabolic remodelling processes. Recent studies, including ours, provided important proof that metabolic remodeling in B cells during their differentiation or proliferation is essential for their functions. Future studies might provide new proof of principle for the role of energy-conversion pathway in B cell differentiation.
The function of HIFs in B cells is of critical importance not only for fundamental knowledge, but also for further therapeutic opportunity. Indeed, it is possible to target the functions of HIFs using small PHD inhibitors. It is however essential to further understand the possible off-target effects of these drugs during diseases treatment such as for intestinal disorders, arthritis and tumorigenesis.
